1st Quarter - Report

CEPHEID for CEPHEID

Period 1st Quarter 2015 Filed Apr 17, 2015 Signed by Hallie Lewis

Official filing
Firm
CEPHEID
Client
CEPHEID
Income
—
Expenses
$50,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Lobbying Issues: Molecular diagnostic tests, infection control and prevention programs (Multidrug resistant organisms (MDRO)), CDC-related issues (MDRO research and surveillance), hospital and other provider quality improvement programs CMS-related issues (reimbursement and coverage policies), FDA oversight, global health funding comparative effectiveness, personalized medicine/pharmacogenomics, Veterans Affairs healthcare-related issues

LobbyistCovered position, as disclosed
HALLIE CHRISTINE LEWIS —
MICHELE M SCHOONMAKER —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ); SENATE; HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Medicare Payment Advisory Commission (MedPAC); Federal Bureau of Investigation (FBI); Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA)

Medicare/Medicaid MMM

Lobbying Issues: Molecular diagnostic tests, infection control and prevention programs (Multidrug resistant organisms (MDRO)), CDC-related issues (MDRO research and surveillance), hospital and other provider quality improvement programs CMS-related issues (reimbursement and coverage policies), FDA oversight, global health funding comparative effectiveness, personalized medicine/pharmacogenomics, Veterans Affairs healthcare-related issues

LobbyistCovered position, as disclosed
HALLIE CHRISTINE LEWIS —
MICHELE M SCHOONMAKER —

Contacted: Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Veterans Affairs, Dept of (VA); Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); SENATE; Federal Bureau of Investigation (FBI); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Lobbying Issues: Molecular diagnostic tests, infection control and prevention programs (Multidrug resistant organisms (MDRO)), CDC-related issues (MDRO research and surveillance), hospital and other provider quality improvement programs CMS-related issues (reimbursement and coverage policies), FDA oversight, global health funding comparative effectiveness, personalized medicine/pharmacogenomics, Veterans Affairs healthcare-related issues

LobbyistCovered position, as disclosed
HALLIE CHRISTINE LEWIS —
MICHELE M SCHOONMAKER —

Contacted: Health & Human Services, Dept of (HHS); Federal Bureau of Investigation (FBI); Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); Medicare Payment Advisory Commission (MedPAC); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.